Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Other Accumulated Expenses: 2013-2025

Historic Other Accumulated Expenses for Ocular Therapeutix (OCUL) over the last 9 years, with Sep 2025 value amounting to $1.9 million.

  • Ocular Therapeutix's Other Accumulated Expenses rose 6.42% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 6.42%. This contributed to the annual value of $2.1 million for FY2024, which is 34.75% up from last year.
  • Per Ocular Therapeutix's latest filing, its Other Accumulated Expenses stood at $1.9 million for Q3 2025, which was up 11.07% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Ocular Therapeutix's Other Accumulated Expenses peaked at $2.1 million during Q4 2024, and registered a low of $699,000 during Q1 2021.
  • For the 3-year period, Ocular Therapeutix's Other Accumulated Expenses averaged around $1.7 million, with its median value being $1.6 million (2025).
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first slumped by 35.58% in 2021, then soared by 61.58% in 2024.
  • Quarterly analysis of 5 years shows Ocular Therapeutix's Other Accumulated Expenses stood at $1.1 million in 2021, then grew by 11.13% to $1.2 million in 2022, then climbed by 24.19% to $1.5 million in 2023, then surged by 34.75% to $2.1 million in 2024, then grew by 6.42% to $1.9 million in 2025.
  • Its Other Accumulated Expenses was $1.9 million in Q3 2025, compared to $1.7 million in Q2 2025 and $1.6 million in Q1 2025.